Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series
BIJSLUITER - Teva Pharma Belgium
Mo better for TEVA with Modag? – The Science of Parkinson's
FOGLIO ILLUSTRATIVO: INFORMAZIONI PER L'UTILIZZATORE Levodopa/Benserazide Teva Italia 200 mg/50 mg Compresse Medicinale equivale
Levodopa | Teva UK
Prospect Levodopa Benserazide - Parkinson
Russia faces shortage of drugs against Parkinson's disease
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink
Levodopa/Benserazid "Teva", komb. - information til sundhedsfaglige - Medicin.dk
Dopamine en médicament | Dopamine.fr
Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
Levodopa | Teva UK
Roche | Madopar (levodopa benserazide)
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
MODOPAR et génériques : mise au point sur les ruptures de stock et les tensions d'approvisionnement
Maladie de Parkinson : remise à disposition de MODOPAR et rupture de stock de SINEMET